Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
Krystal Biotech (NASDAQ: KRYS) has announced its participation in the BofA Securities 2025 Health Care Conference in Las Vegas on May 14, 2025. The company's Chairman and CEO, Krish S. Krishnan, will participate in a fireside chat at 11:20 am PT and conduct investor meetings throughout the day. The presentation will be accessible via webcast and will be available on the company's website in the Investors section.
Krystal Biotech (NASDAQ: KRYS) ha annunciato la sua partecipazione alla BofA Securities 2025 Health Care Conference che si terrà a Las Vegas il 14 maggio 2025. Il Presidente e CEO dell'azienda, Krish S. Krishnan, parteciperà a una conversazione informale alle 11:20 PT e terrà incontri con investitori durante tutta la giornata. La presentazione sarà accessibile tramite webcast e disponibile nella sezione Investitori del sito web aziendale.
Krystal Biotech (NASDAQ: KRYS) ha anunciado su participación en la BofA Securities 2025 Health Care Conference en Las Vegas el 14 de mayo de 2025. El presidente y CEO de la compañía, Krish S. Krishnan, participará en una charla informal a las 11:20 am PT y realizará reuniones con inversores durante todo el día. La presentación estará disponible vía webcast y en la sección de inversores del sitio web de la empresa.
Krystal Biotech (NASDAQ: KRYS)가 2025년 5월 14일 라스베이거스에서 열리는 BofA Securities 2025 Health Care Conference에 참여한다고 발표했습니다. 회사의 회장 겸 CEO인 Krish S. Krishnan이 태평양 표준시 오전 11:20에 파이어사이드 채팅에 참여하며 하루 종일 투자자 미팅을 진행할 예정입니다. 발표는 웹캐스트를 통해 시청할 수 있으며 회사 웹사이트의 투자자 섹션에서 확인할 수 있습니다.
Krystal Biotech (NASDAQ : KRYS) a annoncé sa participation à la BofA Securities 2025 Health Care Conference à Las Vegas le 14 mai 2025. Le président-directeur général de la société, Krish S. Krishnan, prendra part à une discussion informelle à 11h20 PT et tiendra des réunions avec des investisseurs tout au long de la journée. La présentation sera accessible en webcast et disponible dans la section Investisseurs du site internet de l'entreprise.
Krystal Biotech (NASDAQ: KRYS) hat seine Teilnahme an der BofA Securities 2025 Health Care Conference in Las Vegas am 14. Mai 2025 angekündigt. Der Vorsitzende und CEO des Unternehmens, Krish S. Krishnan, wird um 11:20 Uhr PT an einem Fireside-Chat teilnehmen und den ganzen Tag über Investorengespräche führen. Die Präsentation wird per Webcast zugänglich sein und im Bereich Investoren auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference on May 14, 2025, in Las Vegas. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 11:20 am PT and host investor meetings throughout the day.
A webcast of the presentation will be available here beginning at 11:20 am PT on Wednesday, May 14, 2025 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy, and the first genetic medicine approved by the FDA and EMA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).
CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com
FAQ
When is Krystal Biotech (KRYS) presenting at the BofA Securities Healthcare Conference 2025?
Who will represent Krystal Biotech (KRYS) at the BofA Securities Healthcare Conference 2025?
How can investors watch Krystal Biotech's (KRYS) presentation at the BofA Securities conference?
What activities will Krystal Biotech (KRYS) participate in at the BofA Securities conference?
